您当前所在的位置:首页 > 产品中心 > 产品信息
Amoxicillin_分子结构_CAS_26787-78-0)
点击图片或这里关闭

Amoxicillin

产品号 DB01060 公司名称 DrugBank
CAS号 26787-78-0 公司网站 http://www.ualberta.ca/
分子式 C16H19N3O5S 电 话 (780) 492-3111
分子量 365.40416 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 931

产品价格信息

请登录

产品别名

标题
Amoxicillin
IUPAC标准名
(2S,5R,6R)-6-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
IUPAC传统名
amoxicillin
商标名
Amoxil
Sawamox PM
Metafarma capsules
Amoxiden
Sumox
Lamoxy
Piramox
Polymox
Unicillin
Zimox
Amolin
Delacillin
Dispermox
Flemoxin
Hiconcil
Imacillin
Moxal
Pamoxicillin
Tolodina
Vetramox
AMPC
Amoxi
Amoxi-Mast
Amoxibiotic
Amoxivet
Anemolin
Aspenil
Biomox
Bristamox
Cemoxin
Efpenix
Histocillin
Ibiamox
Metifarma capsules
Moxacin
Ospamox
Robamox
Trimox
Utimox
Wymox
Actimoxi
Amoclen
Amopen
Amopenixin
Clamoxyl
别名
Amoxycillin Trihydrate
AMC
D-Amoxicillin
Amoxicilina [INN-Spanish]
Amoxicillin anhydrous
Amoxicilline [INN-French]
Amoxicillinum [INN-Latin]
Amoxicillin Trihydrate
Amoxycillin
p-Hydroxyampicillin

产品登记号

PubChem SID 46507578
CAS号 26787-78-0
PubChem CID 33613

产品性质

疏水性(logP) 0
溶解度 3430 mg/L

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description A broad-spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration. Amoxicillin is commonly prescribed with clauvanic acid (a beta lactamase inhibitor) as it is susceptible to beta-lacatamase degradation. [PubChem]
Indication For the treatment of infections of the ear, nose, and throat, the genitourinary tract, the skin and skin structure, and the lower respiratory tract due to susceptible (only b-lactamase-negative) strains of Streptococcus spp. (a- and b-hemolytic strains only), S. pneumoniae, Staphylococcus spp., H. influenzae, E. coli, P. mirabilis, or E. faecalis. Also for the treatment of acute, uncomplicated gonorrhea (ano-genital and urethral infections) due to N. gonorrhoeae (males and females).
Pharmacology Amoxicillin is a moderate-spectrum antibiotic active against a wide range of Gram-positive, and a limited range of Gram-negative organisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics. Amoxicillin is susceptible to degradation by β-lactamase-producing bacteria, and so may be given with clavulanic acid to increase its susceptability. The incidence of β-lactamase-producing resistant organisms, including E. coli, appears to be increasing. Amoxicillin is sometimes combined with clavulanic acid, a β-lactamase inhibitor, to increase the spectrum of action against Gram-negative organisms, and to overcome bacterial antibiotic resistance mediated through β-lactamase production.
Toxicity Serious toxicity is unlikely following large doses of amoxicillin. Acute ingestion of large doses of amoxicillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses.
Affected Organisms
Enteric bacteria and other eubacteria
Biotransformation Hepatic metabolism accounts for less than 30% of the biotransformation of most penicillins
Absorption Rapidly absorbed after oral administration.
Half Life 61.3 minutes
Protein Binding In blood serum, amoxicillin is approximately 20% protein-bound
Elimination Most of the amoxicillin is excreted unchanged in the urine; its excretion can be delayed by concurrent administration of probenecid.
References
Drawz SM, Bonomo RA: Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010 Jan;23(1):160-201. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

  • Drawz SM, Bonomo RA: Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010 Jan;23(1):160-201. Pubmed